2010
DOI: 10.1038/gt.2010.115
|View full text |Cite
|
Sign up to set email alerts
|

Use of human MAR elements to improve retroviral vector production

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
10
1

Year Published

2011
2011
2020
2020

Publication Types

Select...
8
2

Relationship

0
10

Authors

Journals

citations
Cited by 20 publications
(11 citation statements)
references
References 48 publications
0
10
1
Order By: Relevance
“…However, there have been a few reports of MAR increasing transgene expression within 48 h of transfection (Chancham et al, 2003;Kulkarni et al, 2004). We have also shown that the 1-68 MAR was able to improve retroviral vector titers in transient transfections in the human embryo HEK293 cell line (Buceta et al, 2011). Surprisingly, the S4 MAR rather had a minor negative impact on transient IgG expression, while it had no such effect when cloned in the pGEGFP vector (Fig.…”
Section: S4 Mar Increases Stable But Not Transient Immunoglobulin Expmentioning
confidence: 80%
“…However, there have been a few reports of MAR increasing transgene expression within 48 h of transfection (Chancham et al, 2003;Kulkarni et al, 2004). We have also shown that the 1-68 MAR was able to improve retroviral vector titers in transient transfections in the human embryo HEK293 cell line (Buceta et al, 2011). Surprisingly, the S4 MAR rather had a minor negative impact on transient IgG expression, while it had no such effect when cloned in the pGEGFP vector (Fig.…”
Section: S4 Mar Increases Stable But Not Transient Immunoglobulin Expmentioning
confidence: 80%
“…The MARs of pCCF efficiently and stably increased the transgene expression level. Hence, the use of MAR elements opens new perspectives on the efficient generation of gene therapy vectors (Buceta et al, 2011). Other studies have illustrated that MARs may be used to mediate the sustained or higher expression levels of therapeutic genes, and/or to decrease the viral vector multiplicity of infection required to achieve consistent expression (Harraghy et al, 2008).…”
Section: Transgenic Expressionmentioning
confidence: 99%
“…There are two types of vectors: integrated and non-integrated vectors. Integrated vectors facilitate the insertion of mutations, and may be responsible for diseases arising as a result of the position of the inserted gene (Buceta et al, 2011;Ley et al, 2013). Ideal non-integrated vectors present no potential risk in gene therapy, are stable through mitosis, and express high levels of the transgene (Girod et al, 2007).…”
Section: Introductionmentioning
confidence: 99%